Evaluation of [123I] AV51 and SPECT as a Marker of Beta-amyloid Protein Deposition in Subjects With Alzheimer Disease in Comparison to Healthy Subjects
Clinical trial NCT00556660 · COMPLETED
Trial details
- NCT number
- NCT00556660
- Sponsor
- Institute for Neurodegenerative Disorders
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2007-09-01
- Primary completion
- 2008-07-01
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.